Santé log4h
Steve Aoki Joins Neuro Gum as Investor, Backing the Brand Revolutionizing Mental Performance
LOS ANGELES, Oct. 16, 2024 (GLOBE NEWSWIRE) -- 2X Grammy-nominated producer, DJ, and entrepreneur Steve Aoki has officially ...
Santé log4h
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative ...
Santé log4h
Compass Health delivers mental health services at first school-based health clinic in Bellingham Public Schools
Behavioral health care services are the first phase of the school-based health clinic. Renovations are underway in the existing space to house primary care services delivered by a local health care ...
Santé log4h
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
BMB-201, a selective 5-HT2A/2C receptor agonist, was designed to harness the analgesic potential of serotonin modulation without the hallucinogenic effects commonly associated with 5-HT2A activation.
Santé log4h
FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
Founder & Chief Executive Officer of FibroBiologics, Pete O’Heeron said, “The issuance of this patent recognizes the novelty and utility of using modified fibroblasts to deliver tumor-inhibiting ...
Santé log4h
Acquisition of Ovizio Imaging Systems SA
On the basis of the completed due diligence, ChemoMetec today submitted a binding tender offer for the acquisition of 100% of the shares of Belgian company Ovizio Imaging Systems SA (’Ovizio’). The ...
Santé log4h
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a ...
Santé log4h
Upgrade of revenue and operating profit guidance
Based on this, the Company now expects revenue for the 2024/25 financial year in the DKK 445-460 million range, up from DKK 435-450 million in the most recent guidance, and EBITDA in the DKK 222-230 ...
Santé log4h
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
Under this expanded agreement, Optime Care will now manage commercial distribution for three Rigel products: TAVALISSE, GAVRETO ® (pralsetinib) and Rezlidhia ® (olutasidenib),” says Stephanie ...
Santé log4h
Cepham Prioritizes Women’s Health to Address Research and Innovation Gender Gap
Cepham emphasizes that while it is committed to addressing women’s health, men’s health remains equally crucial. In the coming months, Cepham will share insights on misconceptions in men’s health ...
Santé log4h
SCALE Healthcare Honors USOSM’s Richard Hall for Excellence
IRVING, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) President and CEO Richard Hall recently received the SCALE Community MSO Excellence Award, which recognizes ...
Santé log4h
Renovaro Announces Strategic Restructuring and Leadership Transition
Departing Chairman, Rene Sindlev commented: “We are excited to empower a team of seasoned executives and directors that both see the potential of Renovaro 2.0 (which we call RenoVision) and can design ...